You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
As of Roslin 2.4.2, we run Abra per pair, but we used to run it per group. On a project where Abra operated on 5 BAMs at a time from the same patient (group), it took ~130hrs when limited to a coverage BED file created by GATK's FindCoveredIntervals with min mapping qual 1, min base qual 5, and min-depth 3: http://pi.mskcc.org/roslin/#/?id=Proj_06058_CFO:c53297ec-1723-11e8-8853-645106efb11c
Data: /ifs/res/pi/Proj_06058_CFO.c53297ec-1723-11e8-8853-645106efb11c
Compare resulting mutation lists to quantify drawbacks of limiting Abra to just the targeted regions. If the results are not significantly different, then we will be able to significantly speed up this step that bottlenecks the roslin-variant workflow. In implementation, it would be better to limit Abra to the intersection of coverage and target BED files. E.g. when working with WGS, or when using a superset assay for an older smaller assay for which targets are unknown (http://plvpipetrack1.mskcc.org:8090/browse/RSL-829).
The text was updated successfully, but these errors were encountered:
As of Roslin 2.4.2, we run Abra per pair, but we used to run it per group. On a project where Abra operated on 5 BAMs at a time from the same patient (group), it took ~130hrs when limited to a coverage BED file created by GATK's FindCoveredIntervals with min mapping qual 1, min base qual 5, and min-depth 3:
http://pi.mskcc.org/roslin/#/?id=Proj_06058_CFO:c53297ec-1723-11e8-8853-645106efb11c
Data: /ifs/res/pi/Proj_06058_CFO.c53297ec-1723-11e8-8853-645106efb11c
But it took only ~45hrs limited to the list of targeted regions (Agilent Exons in this run):
http://pi.mskcc.org/roslin/#/?id=Proj_06058_CFO:bb8a6294-1901-11e8-b36c-645106efb11c
Data: /ifs/res/pi/Proj_06058_CFO.bb8a6294-1901-11e8-b36c-645106efb11c - unfortunately we cleaned this up, thinking it was as a duplicate.
Compare resulting mutation lists to quantify drawbacks of limiting Abra to just the targeted regions. If the results are not significantly different, then we will be able to significantly speed up this step that bottlenecks the roslin-variant workflow. In implementation, it would be better to limit Abra to the intersection of coverage and target BED files. E.g. when working with WGS, or when using a superset assay for an older smaller assay for which targets are unknown (http://plvpipetrack1.mskcc.org:8090/browse/RSL-829).
The text was updated successfully, but these errors were encountered: